The Vytorin chatter has died down a bit, but the occasional aftershock is still rattling here and there across the vast plain of the Internet.
Harlan Krumholz, a Yale doc who at a big cardiology conference last weekend cast the drug in a pretty dim light, waded into the online fray yesterday. He was responding to [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment